Lead Product(s): Undisclosed
Therapeutic Area: Hematology Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: LUNAC Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership February 25, 2020
The partnership aims at discovering a drug that inhibits the protease target, activated Factor XII.